142 related articles for article (PubMed ID: 24372990)
1. Clinical predictors of autoimmune and severe atopic disease in pediatric heart transplant recipients.
Mouledoux JH; Albers EL; Lu Z; Saville BR; Moore DJ; Dodd DA
Pediatr Transplant; 2014 Mar; 18(2):197-203. PubMed ID: 24372990
[TBL] [Abstract][Full Text] [Related]
2. Allergies and autoimmune disorders in children after heart transplantation.
Avdimiretz N; Seitz S; Kim T; Murdoch F; Urschel S
Clin Transplant; 2018 Oct; 32(10):e13400. PubMed ID: 30176068
[TBL] [Abstract][Full Text] [Related]
3. De Novo Allergy and Immune-Mediated Disorders Following Solid-Organ Transplantation-Prevalence, Natural History, and Risk Factors.
Marcus N; Amir AZ; Grunebaum E; Dipchand A; Hebert D; Ng VL; Walters T; Avitzur Y
J Pediatr; 2018 May; 196():154-160.e2. PubMed ID: 29395171
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal renal function in pediatric heart transplant recipients: 20-years experience.
Gupta P; Rettiganti M; Gossett JM; Gardner M; Bryant JC; Noel TR; Knecht KR
Pediatr Transplant; 2015 Mar; 19(2):182-7. PubMed ID: 25484128
[TBL] [Abstract][Full Text] [Related]
5. Incidence, predictors, and outcomes after severe primary graft dysfunction in pediatric heart transplant recipients.
Profita EL; Gauvreau K; Rycus P; Thiagarajan R; Singh TP
J Heart Lung Transplant; 2019 Jun; 38(6):601-608. PubMed ID: 30733156
[TBL] [Abstract][Full Text] [Related]
6. Somatic growth in infant heart transplant recipients.
Chinnock R; Baum M
Pediatr Transplant; 1998 Feb; 2(1):30-4. PubMed ID: 10084757
[TBL] [Abstract][Full Text] [Related]
7. Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients.
Kobayashi D; Du W; L'ecuyer TJ
Pediatr Transplant; 2013 Aug; 17(5):436-40. PubMed ID: 23714284
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin inhibitor- and corticosteroid-free immunosuppression in pediatric heart transplant patients.
Sierra CM; Tan R; Eguchi J; Bailey L; Chinnock RE
Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27658616
[TBL] [Abstract][Full Text] [Related]
9. Maintenance steroid use at 30 days post-transplant and outcomes of pediatric heart transplantation: A propensity matched analysis of the Pediatric Heart Transplant Study database.
Auerbach SR; Kukreja M; Gilbert D; Bastardi H; Feingold B; Knecht K; Kaufman BD; Brown RN; Miyamoto SD
J Heart Lung Transplant; 2015 Aug; 34(8):1066-72. PubMed ID: 25980572
[TBL] [Abstract][Full Text] [Related]
10. Infectious, malignant, and autoimmune complications in pediatric heart transplant recipients.
Kulikowska A; Boslaugh SE; Huddleston CB; Gandhi SK; Gumbiner C; Canter CE
J Pediatr; 2008 May; 152(5):671-7. PubMed ID: 18410772
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil in pediatric heart transplant recipients: a single-center experience.
Dipchand AI; Benson L; McCrindle BW; Coles J; West L
Pediatr Transplant; 2001 Apr; 5(2):112-8. PubMed ID: 11328549
[TBL] [Abstract][Full Text] [Related]
12. Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients.
Singh TP; Faber C; Blume ED; Worley S; Almond CS; Smoot LB; Dillis S; Nasman C; Boyle GJ
J Heart Lung Transplant; 2010 May; 29(5):517-22. PubMed ID: 20061164
[TBL] [Abstract][Full Text] [Related]
13. Use of sirolimus in pediatric heart transplant patients: A multi-institutional study from the Pediatric Heart Transplant Study Group.
Rossano JW; Jefferies JL; Pahl E; Naftel DC; Pruitt E; Lupton K; Dreyer WJ; Chinnock R; Boyle G; Mahle WT;
J Heart Lung Transplant; 2017 Apr; 36(4):427-433. PubMed ID: 28029575
[TBL] [Abstract][Full Text] [Related]
14. De novo food sensitization and eosinophilic gastrointestinal disease in children post-liver transplantation.
Wisniewski J; Lieberman J; Nowak-Węgrzyn A; Kerkar N; Arnon R; Iyer K; Miloh T
Clin Transplant; 2012; 26(4):E365-71. PubMed ID: 22694084
[TBL] [Abstract][Full Text] [Related]
15. Immune cell function assay in pediatric heart transplant recipients.
Wong MS; Boucek R; Kemna M; Rutledge J; Law Y
Pediatr Transplant; 2014 Aug; 18(5):485-90. PubMed ID: 24930882
[TBL] [Abstract][Full Text] [Related]
16. Cholelithiasis in infant and pediatric heart transplant patients.
Sakopoulos AG; Gundry S; Razzouk AJ; Andrews HG; Bailey LL
Pediatr Transplant; 2002 Jun; 6(3):231-4. PubMed ID: 12100508
[TBL] [Abstract][Full Text] [Related]
17. Antibody depletion for the treatment of crossmatch-positive pediatric heart transplant recipients.
Daly KP; Chandler SF; Almond CS; Singh TP; Mah H; Milford E; Matte GS; Bastardi HJ; Mayer JE; Fynn-Thompson F; Blume ED
Pediatr Transplant; 2013 Nov; 17(7):661-9. PubMed ID: 23919762
[TBL] [Abstract][Full Text] [Related]
18. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
19. The natural history of renal function following orthotopic heart transplant.
Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B
Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
[TBL] [Abstract][Full Text] [Related]
20. Infection after pediatric heart transplantation: results of a multiinstitutional study. The Pediatric Heart Transplant Study Group.
Schowengerdt KO; Naftel DC; Seib PM; Pearce FB; Addonizio LJ; Kirklin JK; Morrow WR
J Heart Lung Transplant; 1997 Dec; 16(12):1207-16. PubMed ID: 9436132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
